APP and Alzheimer disease: In line with this, ageing-associated decreased levels of miR-186 may contribute to AD pathogenesis since miR-186 targets 3′UTR of BACE1 encoding the β-secretase enzyme that processes APP to Aβ peptides and protects from OS-pathogenesis in AD [136].